How it works: The first medicines: interferon beta and glatiramer acetate →

Plegridy

EU: Approved in the EU since 2014US: FDA approved 2014

Molecule type
Protein
Mechanism (ChEMBL)
Interferon alpha/beta receptor agonist
Targets
Interferon alpha/beta receptor
Availability
Authorised in all EU and EEA countries. Reimbursement is decided by each country.

Approvals

  • EU/EEAPlegridy · Authorised2014-07-18 Source
  • USPlegridy · Approved2014-08-15 Source

Safety communications

None recorded.

Most-reported side effects (FDA reports)

Reports to the FDA's adverse event system (FAERS) show what people and doctors reported while taking the medicine. They do not prove the medicine caused it, and they are not rates.

65 reports in total, 58 marked serious.

  • Multiple sclerosis relapse18
  • Dizziness10
  • Nausea10
  • Off label use7
  • Anaemia6
  • General physical health deterioration6
  • Drug ineffective5
  • Menorrhagia5
  • Drug ineffective for unapproved indication4
  • Therapy non-responder4

Trials

Key trials

Large trials with a reported result on their main goal.

  • Dimethyl fumarate, phase 3

    Terminated · Phase 3 · Relapsing MS · Stopped: safety

  • ALLOW

    Completed · Phase 3 · Relapsing MS · Main goal met

  • ADVANCE

    Completed · Phase 3 · Relapsing MS · Main goal met

Running now

  • DESIRE MS

    Recruiting · Phase 3 · Relapsing and progressive · ongoing

  • TWINS

    Not yet recruiting · Phase 3 · Relapsing MS · ongoing

  • INFORM

    Running, not recruiting · MS (type not specified) · ongoing

  • Alemtuzumab

    Running, not recruiting · Relapsing MS · ongoing

  • Peginterferon beta-1a, phase 3

    Running, not recruiting · Phase 3 · Relapsing MS · ongoing

  • STOP-I-SEP

    Running, not recruiting · Phase 3 · Progressive MS · ongoing

Other trials (12)

Completed small trials, dose-finding studies and trials in other diseases.

  • PERFECT

    Completed · Relapsing MS · no_result_found

  • Acetaminophen, phase 4

    Status unknown · Phase 4 · Relapsing and progressive · result_in_paper_unread

  • PLENO

    Completed · Phase 4 · Relapsing MS · no_result_found

  • Interferon beta-1a

    Completed · MS (type not specified) · no_result_found

  • PLATINUM

    Completed · Phase 4 · Relapsing MS · Main goal not met

  • BRITE

    Withdrawn · Phase 4 · Relapsing MS · stopped_other

  • POP

    Completed · Relapsing MS · no_result_found

  • Interferon beta-1a, phase 1

    Completed · Phase 1 · MS (type not specified) · result_in_paper_unread

  • Frequency

    Withdrawn · Phase 4 · Relapsing MS · stopped_other

  • Dimethyl fumarate

    Completed · MS (type not specified) · result_in_paper_unread

For information only, not medical advice. Talk to your neurologist before changing treatment.

Hypotheses involving this medicine

Loading hypotheses…

Loading reviews and guidelines…

Lab studies

Lab studies in animals or cells. Results in animals often do not hold in people, and these studies never change the status of an idea.

Loading lab studies…

Assembled by software from public sources and not checked by people. Each record links to its source. Report an error